Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Minimally Important Difference of Health Assessment Questionnaire in Psoriatic Arthritis: Relating Thresholds of Improvement in Functional Ability to Patient-rated Importance and Satisfaction

PHILIP J. MEASE, J. MICHAEL WOOLLEY, BOJENA BITMAN, BRIAN C. WANG, DENISE R. GLOBE and AMITABH SINGH
The Journal of Rheumatology November 2011, 38 (11) 2461-2465; DOI: https://doi.org/10.3899/jrheum.110546
PHILIP J. MEASE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pmease@nwlink.com
J. MICHAEL WOOLLEY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BOJENA BITMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BRIAN C. WANG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DENISE R. GLOBE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AMITABH SINGH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Ritchlin CT,
    2. Kavanaugh A,
    3. Gladman DD,
    4. Mease PJ,
    5. Helliwell P,
    6. Boehncke WH,
    7. et al.
    Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009;68:1387–94.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Gottlieb A,
    2. Korman NJ,
    3. Gordon KB,
    4. Feldman SR,
    5. Lebwohl M,
    6. Koo JY,
    7. et al.
    Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 2008;58:851–64.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Gladman DD,
    2. Landewe R,
    3. McHugh NJ,
    4. Fitzgerald O,
    5. Thaci D,
    6. Coates L,
    7. et al.
    Composite measures in psoriatic arthritis: GRAPPA 2008. J Rheumatol 2010;37:453–61.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Mease PJ
    . Assessment tools in psoriatic arthritis. J Rheumatol 2008;35:1426–30.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Stanford University Medical Center
    . ARAMIS: HAQ. [Internet. Accessed July 22, 2011.] Available from: http://aramis.stanford.edu/HAQ.html
  6. 6.↵
    1. Mease PJ,
    2. Antoni CE,
    3. Gladman DD,
    4. Taylor WJ
    . Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis 2005;64 Suppl 2:ii49–54.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Beaton DE,
    2. Boers M,
    3. Wells GA
    . Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol 2002; 14:109–14.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Beaton DE,
    2. Bombardier C,
    3. Katz JN,
    4. Wright JG,
    5. Wells G,
    6. Boers M,
    7. et al.
    Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal clinically important difference. J Rheumatol 2001;28:400–5.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Mease PJ,
    2. Ganguly R,
    3. Wanke L,
    4. Yu E,
    5. Singh A
    . How much improvement in functional status is considered important by patients with active psoriatic arthritis: applying the Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) group guidelines [abstract]. Ann Rheum Dis 2004;63 Suppl 1:SAT0015.
    OpenUrl
  10. 10.↵
    1. Mease PJ,
    2. Kivitz AJ,
    3. Burch FX,
    4. Siegel EL,
    5. Cohen SB,
    6. Ory P,
    7. et al.
    Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept. J Rheumatol 2006;33:712–21.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Mease PJ,
    2. Goffe BS,
    3. Metz J,
    4. VanderStoep A,
    5. Finck B,
    6. Burge DJ
    . Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000;356:385–90.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Mease PJ,
    2. Woolley JM,
    3. Singh A,
    4. Tsuji W,
    5. Dunn M,
    6. Chiou C-F
    . Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis. J Rheumatol 2010;37:1221–7.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Norman GR,
    2. Sloan JA,
    3. Wyrwich KW
    . Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582–92.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Revicki D,
    2. Hays RD,
    3. Cella D,
    4. Sloan J
    . Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008;61:102–9.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Wyrwich KW,
    2. Nienaber NA,
    3. Tierney WM,
    4. Wolinsky FD
    . Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999;37:469–78.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Hays RD,
    2. Woolley JM
    . The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics 2000;18:419–23.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Ware JE Jr.,
    2. Bayliss MS,
    3. Rogers WH,
    4. Kosinski M,
    5. Tarlov AR
    . Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study. JAMA 1996; 276:1039–47.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Mease PJ,
    2. Kivitz AJ,
    3. Burch FX,
    4. Siegel EL,
    5. Cohen SB,
    6. Ory P,
    7. et al.
    Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 2004;50:2264–72.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Redelmeier DA,
    2. Lorig K
    . Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology. Arch Intern Med 1993;153:1337–42.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Kosinski M,
    2. Zhao SZ,
    3. Dedhiya S,
    4. Osterhaus JT,
    5. Ware JE Jr.
    . Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2000;43:1478–87.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Wells GA,
    2. Tugwell P,
    3. Kraag GR,
    4. Baker PR,
    5. Groh J,
    6. Redelmeier DA
    . Minimum important difference between patients with rheumatoid arthritis: the patient’s perspective. J Rheumatol 1993;20:557–60.
    OpenUrlPubMed
  22. 22.↵
    1. Wheaton L,
    2. Pope J
    . The minimally important difference for patient-reported outcomes in spondyloarthropathies including pain, fatigue, sleep, and Health Assessment Questionnaire. J Rheumatol 2010;37:816–22.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Kwok T,
    2. Pope JE
    . Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales. J Rheumatol 2010;37:1024–8.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Wolfe F,
    2. Michaud K,
    3. Strand V
    . Expanding the definition of clinical differences: From minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis. J Rheumatol 2005;32:583–9.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 38, Issue 11
1 Nov 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Minimally Important Difference of Health Assessment Questionnaire in Psoriatic Arthritis: Relating Thresholds of Improvement in Functional Ability to Patient-rated Importance and Satisfaction
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Minimally Important Difference of Health Assessment Questionnaire in Psoriatic Arthritis: Relating Thresholds of Improvement in Functional Ability to Patient-rated Importance and Satisfaction
PHILIP J. MEASE, J. MICHAEL WOOLLEY, BOJENA BITMAN, BRIAN C. WANG, DENISE R. GLOBE, AMITABH SINGH
The Journal of Rheumatology Nov 2011, 38 (11) 2461-2465; DOI: 10.3899/jrheum.110546

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Minimally Important Difference of Health Assessment Questionnaire in Psoriatic Arthritis: Relating Thresholds of Improvement in Functional Ability to Patient-rated Importance and Satisfaction
PHILIP J. MEASE, J. MICHAEL WOOLLEY, BOJENA BITMAN, BRIAN C. WANG, DENISE R. GLOBE, AMITABH SINGH
The Journal of Rheumatology Nov 2011, 38 (11) 2461-2465; DOI: 10.3899/jrheum.110546
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Hemophagocytic Lymphohistiocytosis Gene Variants in Childhood-Onset Systemic Lupus Erythematosus With Macrophage Activation Syndrome
  • The Role of Sural Nerve Biopsy in the Diagnosis of Vasculitis
  • Correlation of Fibromyalgia Survey Questionnaire and Quantitative Sensory Testing Among Patients With Active Rheumatoid Arthritis
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire